Your browser doesn't support javascript.
loading
Imiquimod applied topically: a novel immune response modifier and new class of drug.
Miller, R L; Gerster, J F; Owens, M L; Slade, H B; Tomai, M A.
Affiliation
  • Miller RL; 3M Pharmaceuticals, St. Paul, Minnesota, USA.
Int J Immunopharmacol ; 21(1): 1-14, 1999 Jan.
Article in En | MEDLINE | ID: mdl-10411278
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Adjuvants, Immunologic / Aminoquinolines Limits: Animals / Humans Language: En Journal: Int J Immunopharmacol Year: 1999 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Adjuvants, Immunologic / Aminoquinolines Limits: Animals / Humans Language: En Journal: Int J Immunopharmacol Year: 1999 Document type: Article Affiliation country: Country of publication: